| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cell Biology and Physiology (M.D.H.) and Department of Pharmacology (D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
Address all correspondence and requests for reprints to: D. B. DeFranco, Department of Pharmacology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, Pennsylvania 15261. E-mail: dod1{at}pitt.edu.
Hic-5/androgen receptor (AR) coactivator 55 (ARA55) is a group III LIM domain protein that functions as a nuclear receptor coactivator. In the present study, we examined the mechanism by which Hic-5/ARA55 potentiates glucocorticoid receptor (GR) transactivation in the A1–2 derivative of T47D breast cancer cells. Hic-5/ARA55 is an important component of GR-coactivator complexes in A1–2 cells because ablation of Hic-5/ARA55 expression by RNA interference-mediated silencing reduced GR transactivation. As shown by chromatin immunoprecipitation (ChIP) assays, Hic-5/ARA55 is recruited to glucocorticoid-responsive promoters of the mouse mammary tumor virus, c-fos, and p21 genes in response to glucocorticoid treatment. Results from sequential ChIPs established that Hic-5/ARA55 associates with GR-containing complexes at these promoters. We also used sequential ChIPs to examine Hic-5/ARA55 interactions with other well-characterized nuclear receptor coactivators and detected transcriptional intermediary factor 2, receptor-associated coactivator 3, cAMP response element binding protein-binding protein, and p300 within Hic-5/ARA55 complexes on the mouse mammary tumor virus promoter in hormone-treated cells. Ablation of Hic-5/ARA55 expression resulted in reduction of both transcriptional intermediary factor 2 and p300 recruitment to glucocorticoid-responsive promoters. Hic-5/ARA55 is also associated with the corepressor, nuclear receptor corepressor, on glucocorticoid-responsive promoters in cells not exposed to glucocorticoids. These results suggest that Hic-5/ARA55 is required for optimal GR-mediated gene expression possibly by providing a scaffold that organizes or stabilizes coactivator complexes at some hormone-responsive promoters.
NURSA Molecule Pages Link:
This article has been cited by other articles:
 |
|
 |
|
  Z. Niu, D. Iyer, S. J. Conway, J. F. Martin, K. Ivey, D. Srivastava, A. Nordheim, and R. J. Schwartz Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart PNAS, November 18, 2008; 105(46): 17824 - 17829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al. Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Heitzer and D. B. DeFranco Hic-5/ARA55, a LIM Domain-Containing Nuclear Receptor Coactivator Expressed in Prostate Stromal Cells. Cancer Res., July 15, 2006; 66(14): 7326 - 7333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Saelzler, C. C. Spackman, Y. Liu, L. C. Martinez, J. P. Harris, and M. K. Abe ERK8 Down-regulates Transactivation of the Glucocorticoid Receptor through Hic-5 J. Biol. Chem., June 16, 2006; 281(24): 16821 - 16832. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
